"/> Tocris™ Tocriscreen FDA-Approved Drugs Library | B-LABO France

Tocris™ Tocriscreen FDA-Approved Drugs Library

Réf. : BL-RE-125102Réf. fabricant : 18705706 1 Set
2 888,69 € HT

Drug repurposing library; a library of 190 compounds equivalent to active components of drug formulations approved by the FDA

Quantité
1 Set
Cible
Screening Libraries
Poids de la formule
22978
Marque
Tocris

Tocriscreen FDA-Approved Drugs Library is a library of 190 compounds equivalent to the pharmacologically active components of drug formulations approved by the FDA. Compounds supplied pre-dissolved in DMSO (100 μL, 10 mM solution). Contains compounds covering a diverse range of pharmaceutical targets and therapeutic areas e.g. immunology, oncology. Includes both established therapeutics, e.g. tamoxifen (Cat. No. 0999) & paclitaxel (Cat. No. 1097), as well as more recently approved drugs such as darunavir (Cat. No. 6710) & sorafenib (Cat. No. 6814). Ideal for

in vitro

and

in vivo

Caractéristiques techniques

MarqueTocris
Réf. B-LABOBL-RE-125102
Réf. fabricant18705706
Quantité1 Set
CibleScreening Libraries
Poids de la formule22978
Une question, une configuration particulière ?
Contactez-nous pour un devis.